Earlier Lymphedema Detection May Lead to Better Outcomes
When a green dye was used to detect early signs of breast cancer-related lymphedema, patients tended to have better outcomes with the condition, recent research showed.
HER3-DXd Promising for Breast Cancer Type With ‘Poor Prognosis’
HER3-DXd proved to be safe and efficacious in treating patients with HER3-expressing metastatic breast cancer, recent study results showed.
Increased BRCA1/2 Testing May Improve Patient Outcomes
The current testing rate for BRCA 1/2 mutations is currently 68% in HER2-negative early breast cancer, but eligible patients could receive better care if tested.
Newer and Unconventional Treatment Methods May Better Manage Breast Cancer Side Effects in the Future
From the use of anti-depressants to cryotherapy, researchers continue to explore potential ways to mitigate the side effects that are associated with breast cancer therapy.
Advice for the Newly Diagnosed: How to Play an Active Role in Your Treatment
“Often you think we’re the victim, but there’s a lot that you can do to be your own advocate and participate in your healing,” says stage four metastatic breast cancer thriver Nalie Agustin.
Genetic Testing May Offer More Through Clinical Trial Matching
Genetic testing offers a care team a wealth of knowledge to help them craft treatments, but it also can help match patients to clinical trials for potentially better outcomes.
Financial Assistance Programs Offer Out-of-Pocket Cost Relief to Patients with Cancer
Patients faced with cancer are also faced with tough uphill financial battles, but there are assistance programs that can help.
'Knowledge is Power' in Genetic Testing for Hereditary Cancer
Having the right understanding and information of a patient’s genetics can not only help treat cancer but also help prevent it.
A Metastatic Breast Cancer Thriver Shares the Importance of Understanding Your Diagnosis
Understanding a diagnosis is not just something for a patient's care team, the patient needs to understand their diagnosis as well.
The Importance of Biomarker Testing for Patients and Their Families
Understanding biomarkers specific to breast cancer can guide treatment plans and help families with a history of the disease take preventive measures.
Here's What Patients With Breast Cancer Need to Know About CDK 4/6 Inhibitors
As CDK 4/6 inhibitors become a bigger part of the treatment of breast cancer, CURE® sat down with clinical nurse specialist Patricia Jakel to discuss the essentials about the drug.
Advice to the Newly Diagnosed: Get a Second Opinion
Don’t be worried to get a second opinion — it could save your life.
Utilizing the Patient Perspective as a Patient Advocate
Being a patient with cancer gives you a unique perspective that can become beneficial when serving as an advocate for others.
What to Do After You Hear the Words 'You Have Cancer'
If patients take a deep breath and concentrate on the journey ahead after receiving a diagnosis, they can find a path forward, says one metastatic breast cancer thriver.
Breast Implant-Associated Anaplastic Large Cell Lymphoma: Symptoms, Diagnosis and Treatment
At the 37th Annual Miami Breast Cancer Conference, Dr. Valerie Lemaine discussed the signs and symptoms of BIA-ALCL, as well as how the disease is diagnosed and treated.
Asking the Right Questions as a Patient With Breast Cancer
At the 2020 CURE® Educated Patient Breast Cancer Summit, oncology nurse Patricia Jakel had the chance to discuss the types of questions patients should be asking their care team.
Becoming Your Own Best Advocate and Building a Dream Team to Thrive
At CURE’s Educated Patient Breast Cancer Summit, Stephanie Seban shared the ways a patient can become their own best advocate to thrive through their breast cancer journey.
Educating Patients, and Physicians, On the Importance of Genetic Testing In Breast Cancer
Genetic and genomic testing is vital for patients with breast cancer and not only do patients need to understand why that is, but their physicians as well.
Exercise Programs Improve Outcomes for Patients with Breast Cancer
At the 37th Annual Miami Breast Cancer Conference Dr. Jean-Bernard Durand discussed data that showed how prescribed and personalized exercise programs can improve outcomes for patients with cancer who already face a high risk of cardiovascular disease.
Survivorship Starts at Diagnosis: How Doctors Can Better Understand
“A person becomes a survivor from the point they are diagnosed and for the balance of their lives,” Dr. Don S. Dizon said in a presentation at the 37th Annual Miami Breast Cancer Conference®.
Expert Highlights Need for New Paradigm in Genetic Testing
At the 37th Annual Miami Breast Cancer Conference, Dr. Kevin S. Hughes discussed genetic testing and what health care providers should be doing to identify more individuals at risk for cancer.
Xentuzumab Combination Shows Promise in Advanced Breast Cancer
Xentuzumab in combination with Verzenio, with or without endocrine therapy, may be safe and effective in treating patients with solid tumors and advanced breast cancer.
MONALEESA-7 Trial Follow-Up Shows Maintained, Improved Quality of Life, Work Productivity
Premenopausal women with HR-positive, HER2-negative advanced breast cancer experienced improved survival and quality of life with the addition of Kisqali to Zoladex and endocrine therapy to their treatment regimen.
Study Finds No Difference in Psychosocial Scores Following Contralateral Mastectomy
Women who had contralateral prophylactic mastectomy reported similar breast satisfaction and quality of life, cancer-related distress and anxiety and depression scores, compared with those who did not undergo the procedure.
2 Commerce Drive Cranbury, NJ 08512